Redox Balance as the Foundation of Biological Stability

Redox balance is not a battle between “good antioxidants” and “bad free radicals”

A living cell does not need a chemically sterile environment without oxidation. It needs a dynamic regulatory space in which reactive molecules can transmit information without their concentration, location or duration exceeding the cell’s ability to preserve its structure and function. This is why the traditional image of oxidative stress as a simple battle between “bad free radicals” and “good antioxidants” may be easy to understand, but it is biologically inadequate. Modern redox biology describes a far more complex system in which reactive oxygen, nitrogen and sulfur species participate in the regulation of metabolism, immunity, cellular signalling, adaptation to load and responses to the environment.

The term redox combines reduction and oxidation — processes based on electron transfer. Normal cellular energetics would not exist without them. The mitochondrial electron transport chain itself depends on controlled electron flow, while couples such as NAD⁺/NADH, NADP⁺/NADPH and reduced/oxidised glutathione are among the systems through which cells connect metabolism, signalling and protection. Oxidation is therefore not a malfunction of a biological system. It is a natural part of it. What matters is whether reactivity remains within a range that the cell can localise, interpret and regulate.

This is why one of the original statements in this article remains entirely valid: redox balance is not stillness. It is precisely controlled movement.

Redox homeodynamics is the more precise concept

The word balance can evoke the idea of one fixed point to which a cell must always return. Biological reality is more dynamic. An important modern review by Sies, Mailloux and Jakob in Nature Reviews Molecular Cell Biology uses the term redox homeodynamics to describe the dynamic maintenance of a functional redox range. The redox “set point” is not a fixed number. It differs between cells and tissues and changes over time, with physical activity, sleep, immune activation, food intake and the wider exposome.

For TANVEA, this concept is particularly important because it describes biological stability not as immobility, but as the ability of a system to respond without losing regulation and then return to a functional range. A healthy organism must be able to increase metabolic activity, generate ROS during movement, activate an immune response, temporarily alter its redox state and subsequently downregulate or reorganise these processes. Stability is therefore not the absence of response. It is regulatory competence.

This is where redox biology naturally meets TANVEA Biological Systems™. Recovery is not an attempt to “switch off” living biology. It is the restoration of the biological system’s ability to change its own activity precisely according to need.

Oxidative eustress: the body needs part of the oxidative response

One of the most important developments in modern terminology is the distinction between oxidative eustress and oxidative distress. Oxidative eustress describes physiological redox signalling occurring within a controlled range. Reactive molecules are not merely metabolic by-products in this context; they act as carriers of biological information. Their concentration matters, but so do their location, timing and the ability of regulatory systems to terminate the response.

Physical activity is an excellent example. Exercise temporarily increases ROS production, but part of this response belongs to the signals through which the organism adapts. In the well-known controlled human experiment by Ristow and colleagues, high doses of vitamins C and E attenuated some exercise-induced changes associated with insulin sensitivity and the expression of endogenous antioxidant defence mechanisms. This single study does not mean that antioxidants are generally harmful or should never be used. It demonstrates a more important principle: the biological effect of reactive species depends on context, and broadly suppressing oxidative signalling is not always a desirable objective.

This is precisely why TANVEA does not want to reduce recovery to the goal of achieving the lowest possible amount of ROS. The organism does not need the least possible redox signalling. It needs regulation precise enough for a physiological signal to remain a signal rather than progress into uncontrolled biological damage.

The redox system has two boundaries: oxidative and reductive distress

Once we move beyond the simple model of “oxidation bad, reduction good”, another side of redox biology appears. A biological system can deviate not only in an excessively oxidative direction but also in an excessively reductive one. Modern literature uses the term reductive stress for a state in which reducing equivalents, such as NADH or NADPH, accumulate and the relationship between reduced and oxidised forms shifts outside the physiological range.

Such an environment is not automatically “healthier because it is more antioxidant”. Excess NADH can overload electron flow through the mitochondrial respiratory chain and, under some conditions, paradoxically promote further ROS generation. Reductive stress is therefore increasingly investigated as a biologically important component of metabolic reprogramming and mitochondrial dysfunction.

This refines the central argument of the article even further. The goal of redox protection is not to push the cell as far as possible toward reduction. The goal is to preserve a functional homeodynamic space between oxidative and reductive deviation. Biological stability therefore does not arise from the maximum possible antioxidant dose, but from the system’s ability to regulate electron flow, the generation of reactive species and their subsequent biological use.

Not all ROS are the same — and this is where the molecular hydrogen story began

The phrase “free radicals” can create the impression of one homogeneous group of dangerous molecules. In reality, individual reactive species differ fundamentally in chemical reactivity, lifetime, localisation and biological role. Hydrogen peroxide can function as an important signalling molecule at controlled concentrations, whereas the hydroxyl radical is among the most highly reactive species and can initiate extremely rapid chemical reactions in the immediate vicinity of biological structures.

This distinction formed the basis of the landmark 2007 study by Ohsawa and colleagues that helped launch much of modern molecular-hydrogen research. In experimental models, the authors observed a selective biological effect of H₂ against highly reactive oxygen species without the same suppression of some physiologically relevant ROS. This study was historically fundamental to the field, but today it should be understood as the beginning of the mechanistic story rather than its final explanation.

More recent biophysical work has highlighted an important limitation of the simple model: the direct reaction of H₂ with hydroxyl radicals in an aqueous environment may not, by itself, be fast enough to satisfactorily explain the broad and sometimes longer-lasting biological responses observed in molecular-hydrogen research. This is one reason scientific attention has gradually shifted away from the concept of a simple “selective antioxidant” and toward signalling, mitochondria and regulatory networks.

The organism already has its own antioxidant systems

The human body is not a passive object waiting for an external molecule to “clean” oxidation away. It possesses extensive endogenous protective networks including superoxide dismutases, catalase, the glutathione system, thioredoxin mechanisms, NADPH-dependent processes and many redox-sensitive regulatory pathways. These systems are not simply a fire brigade protecting against damage. They are part of redox communication itself.

The question “how much more antioxidant do we need to add?” is therefore often biologically less precise than asking whether the body’s own protective and adaptive systems can maintain their regulatory range under a particular load. This is exactly where molecular hydrogen becomes more interesting than in the marketing image of an external “radical cleaner”.

H₂ should increasingly be studied as a molecule whose biological action probably cannot be explained by simple chemical neutralisation alone. Newer evidence makes this interpretation considerably stronger.

RISP and Complex III: an important mechanistic shift, not a new dogma

An important development came from the work of Negishi and colleagues published in Redox Biology in late 2025. In cellular models and mouse liver, the authors observed induction of the mitochondrial unfolded protein response UPRmt, a transient reduction in Complex III activity and LONP1-dependent degradation of the Rieske iron-sulfur protein RISP. Based on these results, they identified RISP as a primary target of H₂ within their experimental model and interpreted molecular hydrogen as a biologically active signalling molecule rather than merely an inert scavenger.

In the superfinal TANVEA version, however, we use more precise language: RISP is a highly interesting candidate primary target of H₂ in this experimental model, not a definitively established sole receptor or entry point for molecular hydrogen in the human organism. Already in early 2026, Ostojic pointed out that RISP may be an important mediator or “sentinel”, while evolutionary and structural reasoning also opens the possibility of other candidates — including SDHB, iron-sulfur subunits of Complex I and CISD proteins.

This is how a scientific model should evolve. One new mechanism should not replace an old marketing dogma with a new mechanistic dogma. It should open a more precise and more testable view of biological signalling.

Mitochondrial quality control extends the story far beyond “antioxidant”

A review published in May 2026 takes the interpretation of molecular H₂ another step further. Li, Jing and colleagues organise current evidence around mitochondrial quality control and metabolic reprogramming. They discuss mitochondrial biogenesis, dynamics, mitophagy and regulatory axes involving AMPK/Sirtuins, PGC-1α, PPARα and Nrf2, while repeatedly emphasising the heterogeneity of the underlying models and the fact that upstream initiating events for H₂ remain unresolved.

This is highly relevant for TANVEA. H₂ can no longer be responsibly communicated only through the statement “it reduces oxidative stress”. If the molecule influences — directly or indirectly — proteostasis, mitochondrial quality and metabolic adaptation, its biological effect may not appear simply as a reduction in one oxidative biomarker.

At the same time, the boundaries of the evidence need to remain clear. A substantial proportion of these mechanisms comes from preclinical or heterogeneous models. Biological plausibility is not the same as clinical efficacy in humans.

Fe-porphyrins and hematin: a new mechanistic model from August 2026

The most recent major mechanistic layer appeared only after the August master had already been written. A review by Sano and colleagues published online on 29 August 2026 in the Journal of Cardiology develops a model of oxidised Fe-porphyrins, particularly hematin, as possible redox biosensors for molecular hydrogen. The authors propose a catalytic mechanism that may help explain the so-called “hydrogen paradox” — the apparent discrepancy between the relatively slow direct reaction of H₂ with hydroxyl radicals in an aqueous environment and the broader biological effects observed in experimental systems.

The authors extend the model to high-valent iron species in myeloperoxidase and mitochondrial Complex IV. It is a chemically sophisticated and highly interesting framework, but TANVEA will not present it as a definitive solution to the mechanism of H₂. It represents another emerging mechanistic line that needs independent verification and should be considered alongside the RISP/Fe-S hypotheses and broader mechanisms of mitochondrial regulation.

The scientifically responsible picture today is therefore not “we now know how H₂ works”. It is more interesting than that: the simple selective-antioxidant model is probably insufficient, and several biologically and chemically testable mechanisms are emerging that may explain different parts of the response.

Clinical reality is more complex than the slogan “hydrogen reduces oxidative stress”

If molecular hydrogen acted only as a simple broad-spectrum antioxidant, we might expect oxidative biomarkers to move in a fairly consistent direction. Human data do not show such a simple picture.

In a randomised, double-blind controlled study, healthy adults consumed 1.5 litres of hydrogen-rich water per day for four weeks. Changes in biological antioxidant potential, derivatives of reactive oxygen species and 8-oxo-dG did not differ significantly between groups overall, even though investigators simultaneously reported lower apoptosis of peripheral blood mononuclear cells and changes in transcriptomic networks related to NF-κB and inflammatory signalling. That is a far more complex biological picture than simply saying “oxidative stress decreased”.

A longer 24-week randomised study in people with metabolic syndrome examined high-concentration HRW in a very different metabolic context and reported changes in several metabolic and inflammatory parameters. The result cannot simply be transferred to healthy people, but it clearly illustrates that baseline biological state is part of the response.

The most instructive newer example comes from a randomised, blinded, placebo-controlled study in people with chronic mountain sickness. After eight weeks of consuming 990 mL of HRW per day, total antioxidant capacity increased compared with placebo, but malondialdehyde MDA — a marker of lipid peroxidation — also increased, with a more pronounced rise in participants with BMI ≥24. The authors therefore did not interpret the findings as simple antioxidant protection.

This result is almost a model example for an article about redox balance. Higher antioxidant capacity does not automatically mean lower oxidative damage. A single biomarker cannot replace the broader redox context, and biological effects cannot responsibly be reduced to one number.

More H₂ therefore cannot automatically be equated with a greater biological effect

Once molecular hydrogen is no longer viewed merely as a chemical scavenger, the idea that “more H₂ must be better” becomes even more problematic. Concentration in water, total molecular dose or generator flow during inhalation are relevant technical parameters, but they are not biological outcomes in themselves.

Current reviews of H₂ delivery strategies emphasise differences in stability, bioavailability, distribution and the possibilities for targeted delivery. Oral hydrogen-rich water and inhalation are therefore not simply “weaker” and “stronger” forms of the same thing. They create different temporal and distribution profiles of exposure, and findings from one route cannot automatically be transferred to another.

The superfinal TANVEA version therefore follows a precise principle: the technical parameter must be measured, the actual exposure must be understood and the biological significance must be interpreted. None of these is automatically synonymous with clinical effect.

This applies to hydrogen water, inhalation and other exposure routes within Hydrogen Systems™.

Biological stability does not mean immobility

When TANVEA speaks about biological stability, we do not mean an organism in which nothing changes. A stable living system must respond. It must increase energy turnover during movement, alter its redox state, activate immune responses, respond to heat, cold, light, fasting or physical stress and then be able to return to a functional range.

This is why redox homeodynamics is a more precise concept than perfectly static balance. A biologically stable organism is not an organism without ROS. It is one that can generate ROS, localise them, use them as signals and subsequently regulate them without the response progressing into oxidative or reductive distress.

Recovery, then, is not the silencing of this dynamic. It is the restoration of its precision.

Hydrogen Systems™ are not a system against oxidation

This is a boundary TANVEA intends to keep completely clear. TANVEA Hydrogen Systems™ do not mean that fewer ROS are always better. They do not mean that a higher H₂ concentration is always better. And they do not mean an attempt to eliminate the organism’s natural oxidative activity.

Molecular hydrogen is interesting precisely because its current scientific story is moving away from the simple language of an “antioxidant” toward redox signalling, mitochondrial proteostasis, quality control, metabolic regulation and new candidate molecular mechanisms.

This does not mean that we have one final answer for how H₂ works in humans. It means that we now have very good reasons to stop describing it through the simplistic language of a “powerful antioxidant”.

For TANVEA, the more appropriate question is different: how can a specific form of H₂ exposure fit into a wider environment in which the organism preserves its ability to regulate its own biology precisely?

Scientific mechanism and a health claim are not the same thing

The more interesting mechanistic science becomes, the more important it is not to automatically convert it into a marketing health promise. A cellular mechanism, an animal experiment, a clinical study in a specific population and an authorised claim for a specific consumer product represent four different levels of evidence and communication.

In the European Union, commercial communication about foods and their components is governed by Regulation (EC) No 1924/2006 on nutrition and health claims, while the list of permitted claims is further defined by Commission Regulation (EU) No 432/2012. For new health claims, EFSA scientifically evaluates the supporting evidence before the European Commission, together with Member States, decides on authorisation.

For TANVEA, this creates a clear discipline: what research has shown, what can be biologically interpreted from it and what can lawfully and responsibly be communicated about a specific product are not the same thing. Trust is not built by saying the maximum possible. It is built by knowing precisely where a claim needs to stop.

The central idea

Redox balance does not mean eliminating all reactive molecules from the body. More precisely, it is about redox homeodynamics — the organism’s ability to generate, use and terminate redox signals at the right place, intensity and time. Physiological oxidative eustress is part of normal life; problems arise when the system shifts toward oxidative or reductive distress and loses regulatory precision.

Molecular hydrogen is therefore biologically more interesting today as a potential modulator of the redox and mitochondrial environment than as a marketing-simplified “antioxidant”. Research into RISP and other Fe-S proteins, mitochondrial quality control and oxidised Fe-porphyrins is opening new mechanistic lines, but none of these currently justifies the claim that a single definitive mechanism of H₂ has been established.

The deeper redox biology and H₂ research progress, the less sense it makes to measure the quality of biological protection by the number of “neutralised radicals”.

Biological stability is not the minimum possible reactivity. It is the maximum regulatory precision an organism can sustainably maintain.

Safety and non-medical framework

This article is informational and educational in nature. Molecular hydrogen and TANVEA Hydrogen Systems™ are not presented here as diagnosis, treatment, disease prevention or a substitute for healthcare. Mechanistic findings from cellular and animal models, as well as clinical results in specific populations, cannot automatically be generalised to every person, route of exposure or consumer product.

For people with a medical condition, ongoing treatment, an acute illness, recent surgery, pregnancy or another higher-risk situation, the suitability of adjunctive wellness and recovery technologies should be assessed with a qualified healthcare professional.

---

FAQ

What is redox balance?

Redox balance describes the regulation of oxidation-reduction processes in a biological system. The more precise modern term is redox homeodynamics because the system is not organised around one static point, but around a dynamically regulated range in which reactive molecules can perform signalling functions without progressing into pathological distress.

Are all free radicals and ROS harmful?

No. Reactive species also have physiological signalling functions and participate in adaptation, immunity and metabolic regulation. Their biological significance depends on the chemical species, concentration, localisation and duration.

What is oxidative eustress?

Oxidative eustress describes physiological oxidative signalling occurring within a range that remains under regulatory control. It is the opposite of the assumption that every increase in ROS automatically represents damage. If reactivity exceeds the appropriate range or persists for too long, it can progress into oxidative distress.

What is reductive stress?

Reductive stress is a state in which the redox environment shifts excessively toward reduced forms, for example through an excess of NADH or NADPH. An overly reduced environment is not automatically biologically beneficial and can disrupt mitochondrial function and metabolic regulation.

Is molecular hydrogen an antioxidant?

Historically, H₂ was primarily explained through selective effects on highly reactive species. Current research, however, presents a much broader picture involving mitochondrial signalling, proteostasis, quality control and redox regulation. The simple label “antioxidant” no longer captures the entire mechanistic picture.

Is RISP the definitive receptor for molecular hydrogen?

No. Negishi and colleagues identified RISP as a primary target in their experimental model, but subsequent scientific discussion suggests that other mitochondrial Fe-S proteins may also be relevant. The definitive primary entry point for H₂ signalling in humans has not yet been established.

Does a higher H₂ dose automatically mean a greater effect?

No. A higher technical dose or concentration can mean greater potential exposure under comparable conditions, but the biological response does not necessarily increase linearly. It also depends on administration route, distribution, biological state and the outcome being measured.

Is hydrogen water a weaker form of inhalation?

It is not scientifically appropriate to create such a universal hierarchy. Hydrogen water and inhalation create different exposure and pharmacokinetic profiles, and findings from one route cannot automatically be transferred to the other.

Does higher antioxidant capacity automatically mean less oxidative damage?

No. A recent randomised study in chronic mountain sickness reported increases in both total antioxidant capacity and MDA after HRW. Individual redox biomarkers therefore need to be interpreted within the wider biological context.

---

SCIENTIFIC FOUNDATION AND SELECTED SOURCES

Sies H., Mailloux R.J., Jakob U. Fundamentals of redox regulation in biology. Nature Reviews Molecular Cell Biology. 2024;25:701–719. A key modern review of redox homeodynamics, the redox code and transitions between eustress and oxidative/reductive distress.

Sies H. Oxidative eustress: On constant alert for redox homeostasis. Redox Biology. 2021;41:101867. DOI: 10.1016/j.redox.2021.101867. Conceptual framework for oxidative eustress, homeodynamic range and spatial-temporal redox signalling.

Ristow M. et al. Antioxidants prevent health-promoting effects of physical exercise in humans. PNAS. 2009;106(21):8665–8670. DOI: 10.1073/pnas.0903485106. Controlled human experiment illustrating the role of ROS in adaptive processes during physical exercise.

Ohsawa I., Ishikawa M., Takahashi K. et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. 2007;13:688–694. Historically pivotal experimental work in modern molecular-hydrogen research.

Sim M. et al. Hydrogen-rich water reduces inflammatory responses and prevents apoptosis of peripheral blood cells in healthy adults: a randomized, double-blind, controlled trial. Scientific Reports. 2020. Human RCT illustrating that the biological effects of H₂ cannot be reduced to a uniform decrease in oxidative biomarkers.

LeBaron T.W. et al. The Effects of 24-Week, High-Concentration Hydrogen-Rich Water on Body Composition, Blood Lipid Profiles and Inflammation Biomarkers in Men and Women with Metabolic Syndrome: A Randomized Controlled Trial. Diabetes, Metabolic Syndrome and Obesity. 2020. RCT illustrating the importance of population and long-term protocol when interpreting clinical evidence.

Negishi S. et al. The Rieske iron-sulfur protein is a primary target of molecular hydrogen. Redox Biology. 2025;88:103952. DOI: 10.1016/j.redox.2025.103952. Experimental RISP–Complex III–LONP1–UPRmt mechanistic line.

Ostojic S.M. Revisiting molecular hydrogen signaling in mitochondria: Is the Rieske protein the entry point or a downstream sentinel? Redox Biology. 2026;89:104003. DOI: 10.1016/j.redox.2026.104003. Critical expansion of the RISP model toward additional mitochondrial Fe-S candidates.

Li F., Jing Y. et al. Molecular Hydrogen as a Regulator of Mitochondrial Quality Control and Metabolic Reprogramming. International Journal of Molecular Sciences. 2026;27(11):4948. DOI: 10.3390/ijms27114948. Review of mitochondrial quality control, biogenesis, mitophagy and metabolic regulation in relation to H₂.

Sano M., Shibuya M., Uchinoumi H. et al. Paradigm shift in hydrogen medicine: Target molecules and catalytic mechanisms elucidated at the atomic level. Journal of Cardiology. Published online 29 August 2026. DOI: 10.1016/j.jjcc.2026.08.007. New Fe-porphyrin/hematin mechanistic model of H₂.

Zhang F. et al. Does Hydrogen-Rich Water Reduce Oxidative Stress in Patients with Chronic Mountain Sickness? A Randomized, Blinded, Controlled Trial. High Altitude Medicine & Biology. 2026;27:133–142. RCT showing parallel increases in T-AOC and MDA, important for context-dependent interpretation of redox biomarkers.

Nguyen L.-D.-H. et al. Advances in hydrogen delivery strategies for therapeutic applications. Advanced Drug Delivery Reviews. 2026;228:115734. DOI: 10.1016/j.addr.2025.115734. Review of H₂ stability, bioavailability and differences between exposure routes.

Yang R., Guo Z., Li B. NADH reductive stress drives metabolic reprogramming. Trends in Cell Biology. 2025. Review of reductive stress and its relationship with metabolic reprogramming.

EU regulatory framework: Regulation (EC) No 1924/2006 of the European Parliament and of the Council; Commission Regulation (EU) No 432/2012; EFSA Health Claim Application Procedure.